Evaluation of the Effect of Food on the Pharmacokinetics of SHR6390, An Oral CDK4/6 Inhibitor, in Healthy Volunteers

IF 2.2 4区医学 Q3 PHARMACOLOGY & PHARMACY

Drugs in Research & Development Pub Date : 2022-05-30 DOI:10.1007/s40268-022-00390-7

Yan-ping Liu, M. Hu, Ping-ping Lin, Ting Li, Shu-qin Liu, Yu-ya Wang, Shaorong Li, Xiang-kun Li, Chenjing Wang, Yu Cao

引用次数: 2

Abstract Image

查看原文本刊更多论文

食物对口服CDK4/6抑制剂SHR6390在健康志愿者体内药代动力学影响的评价

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drugs in Research & Development Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

5.10

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： Drugs in R&D is an international, peer reviewed, open access, online only journal, and provides timely information from all phases of drug research and development that will inform clinical practice. Healthcare decision makers are thus provided with knowledge about the developing place of a drug in therapy. The Journal includes: Clinical research on new and established drugs; Preclinical research of direct relevance to clinical drug development; Short communications and case study reports that meet the above criteria will also be considered; Reviews may also be considered.